Shared predisposition in the association between cannabis use and subcortical brain structure

JAMA Psychiatry

Volumn 72, Issue 10, 2015, Pages 994-1001

  Pagliaccio, David ^a   Barch, Deanna M ^a,b,c   Bogdan, Ryan ^a   Wood, Phillip K ^d   Lynskey, Michael T ^e   Heath, Andrew C ^b   Agrawal, Arpana ^b  

^a WASHINGTON UNIVERSITY   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF MISSOURI   (United States)

^e KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; CANNABIS; ILLICIT DRUG;

ADULT; AMYGDALOID NUCLEUS; ARTICLE; BRAIN SIZE; CANNABIS USE; CONTROLLED STUDY; DELAY DISCOUNTING; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; FEMALE; FOLLOW UP; GENETIC CORRELATION; HEREDITY; HIPPOCAMPUS; HUMAN; MAJOR CLINICAL STUDY; MALE; NEUROIMAGING; ORBITAL CORTEX; SIBLING; SMOKING; TWIN DISCORDANCE; VENTRAL STRIATUM; AMYGDALA; BRAIN; CANNABIS SMOKING; CROSS-SECTIONAL STUDY; DIZYGOTIC TWINS; FRONTAL LOBE; GENETIC PREDISPOSITION; GENETICS; MONOZYGOTIC TWINS; NUCLEAR MAGNETIC RESONANCE IMAGING; ORGAN SIZE; PATHOLOGY; STATISTICAL MODEL; TWINS;

ADULT; AMYGDALA; BRAIN; CROSS-SECTIONAL STUDIES; FEMALE; FRONTAL LOBE; GENETIC PREDISPOSITION TO DISEASE; HIPPOCAMPUS; HUMANS; LINEAR MODELS; MAGNETIC RESONANCE IMAGING; MALE; MARIJUANA SMOKING; ORGAN SIZE; SIBLINGS; TWINS, DIZYGOTIC; TWINS, MONOZYGOTIC; VENTRAL STRIATUM;

EID: 84943521853     PISSN: 2168622X     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamapsychiatry.2015.1054     Document Type: Article

References (39)

1. Degenhardt L, Whiteford HA, Ferrari AJ, et al. Global burden of disease attributable to illicit drug use and dependence: findings from the Global Burden of Disease Study 2010. Lancet. 2013;382 (9904):1564-1574.
2. Hall W, Lynskey M. The challenges in developing a rational cannabis policy. Curr Opin Psychiatry. 2009;22(3):258-262.
3. Room R. Cannabis legalization and public health: legal niceties, commercialization and countercultures. Addiction. 2014;109(3):358-359.
4. Volkow ND, Baler RD, Compton WM, Weiss SRB. Adverse health effects of marijuana use. N Engl J Med. 2014;370(23):2219-2227.
5. Lorenzetti V, Lubman DI, Whittle S, Solowij N, Yucel M. Structural MRI findings in long-term cannabis users: what dowe know? Subst Use Misuse. 2010;45(11):1787-1808.
6. Rocchetti M, Crescini A, Borgwardt S, et al. Is cannabis neurotoxic for the healthy brain? a meta-analytical review of structural brain alterations in non-psychotic users. Psychiatry Clin Neurosci. 2013;67(7):483-492.
7. Gilman JM, Kuster JK, Lee S, et al. Cannabis use is quantitatively associated with nucleus accumbens and amygdala abnormalities in young adult recreational users. J Neurosci. 2014;34(16): 5529-5538.
8. Cheetham A, Allen NB, Whittle S, Simmons JG, Yucel M, Lubman DI. Orbitofrontal volumes in early adolescence predict initiation of cannabis use: a 4-year longitudinal and prospective study. Biol Psychiatry. 2012;71(8):684-692.
9. Jacobus J, Squeglia LM, Infante MA, Bava S, Tapert SF. White matter integrity pre- and post marijuana and alcohol initiation in adolescence. Brain Sci. 2013;3(1):396-414.
10. Kendler KS, Neale MC, MacLean CJ, Heath AC, Eaves LJ, Kessler RC. Smoking and major depression: a causal analysis. Arch Gen Psychiatry. 1993;50(1):36-43.
11. Lynskey MT, Heath AC, Bucholz KK, et al. Escalation of drug use in early-onset cannabis users vs co-twin controls. JAMA. 2003;289(4):427-433.
12. Gilbertson MW, Shenton ME, Ciszewski A, et al. Smaller hippocampal volume predicts pathologic vulnerability to psychological trauma. Nat Neurosci. 2002;5(11):1242-1247.
13. Lessov-Schlaggar CN, Lepore RL, Kristjansson SD, et al. Functional neuroimaging study in identical twin pairs discordant for regular cigarette smoking. Addict Biol. 2013;18(1):98-108.
14. Van Essen DC, Ugurbil K, Auerbach E, et al; WU-Minn HCP Consortium. The Human Connectome Project: a data acquisition perspective. Neuroimage. 2012;62(4):2222-2231.
15. Glasser MF, Sotiropoulos SN, Wilson JA, et al; WU-Minn HCP Consortium. Theminimal preprocessing pipelines for the Human Connectome Project. Neuroimage. 2013;80(C):105-124.
16. Dale AM, Fischl B, Sereno MI. Cortical surface-based analysis, I: segmentation and surface reconstruction. Neuroimage. 1999;9(2):179-194.
17. Fischl B, van der Kouwe A, Destrieux C, et al. Automatically parcellating the human cerebral cortex. Cereb Cortex. 2004;14(1):11-22.
18. Desikan RS, Segonne F, Fischl B, et al. An automated labeling system for subdividing the human cerebral cortex on MRI scans into gyral based regions of interest. Neuroimage. 2006;31(3): 968-980.
19. Bucholz KK, Cadoret R, Cloninger CR, et al. A new, semi-structured psychiatric interview for use in genetic linkage studies: a report on the reliability of the SSAGA. J Stud Alcohol. 1994;55(2): 149-158.
20. Gershon RC, Slotkin J, Manly JJ, et al. IV, NIH Toolbox Cognition Battery (CB): measuring language (vocabulary comprehension and reading decoding). Monogr Soc Res Child Dev. 2013;78(4): 49-69.
21. R Development Core Team. R: A Language and Environment for Statistical Computing. Vienna, Austria: R Foundation for Statistical Computing; 2013.
22. Canty A, Ripley B. boot: Bootstrap R (S-Plus) Functions [computer program]. R package version 1.3-17. Vienna, Austria: R Foundation for Statistical Computing; 2012.
23. Blangero J, Almasy L. Solar: Sequential Oligogenic Linkage Analysis Routines: Population Genetics Laboratory Technical Report No. 6. San Antonio, TX: Southwest Foundation for Biomedical Research; 1996.
24. Evans DM, Gillespie NA, Martin NG. Biometrical genetics. Biol Psychol. 2002;61(1-2):33-51.
25. Bates D, Maechler M, Bolker B. lme4: Linear Mixed-Effects Models Using S4 Classes. Vienna, Austria: R Foundation for Statistical Computing; 2012.
26. Cousijn J, Wiers RW, Ridderinkhof KR, van den Brink W, Veltman DJ, Goudriaan AE. Grey matter alterations associated with cannabis use: results of a VBM study in heavy cannabis users and healthy controls. Neuroimage. 2012;59(4):3845-3851.
27. Schacht JP, Hutchison KE, Filbey FM. Associations between cannabinoid receptor-1 (CNR1) variation and hippocampus and amygdala volumes in heavy cannabis users. Neuropsychopharmacology. 2012;37(11):2368-2376.
28. Yucel M, Solowij N, Respondek C, et al. Regional brain abnormalities associated with long-term heavy cannabis use. Arch Gen Psychiatry. 2008;65(6):694-701.
29. Agrawal A, Neale MC, Prescott CA, Kendler KS. A twin study of early cannabis use and subsequent use and abuse/dependence of other illicit drugs. Psychol Med. 2004;34(7):1227-1237.
30. Weiland BJ, Thayer RE, Depue BE, Sabbineni A, Bryan AD, Hutchison KE. Daily marijuana use is not associated with brain morphometric measures in adolescents or adults. J Neurosci. 2015;35(4):1505-1512.
31. Hall W. What has research over the past two decades revealed about the adverse health effects of recreational cannabis use? Addiction. 2015;110(1): 19-35.
32. Battistella G, Fornari E, Annoni J-M, et al. Long-term effects of cannabis on brain structure. Neuropsychopharmacology. 2014;39(9):2041-2048.
33. Adolescent Brain Cognitive Development Study. http://addictionresearch.nih.gov/adolescent -brain-cognitive-development-study. Accessed March 14, 2015.
34. Hanson JL, Nacewicz BM, Sutterer MJ, et al. Behavioral problems after early life stress: contributions of the hippocampus and amygdala. Biol Psychiatry. 2015;77(4):314-323.
35. Sartor CE, Waldron M, Duncan AE, et al. Childhood sexual abuse and early substance use in adolescent girls: the role of familial influences. Addiction. 2013;108(5):993-1000.
36. Burston JJ, Wiley JL, Craig AA, Selley DE, Sim-Selley LJ. Regional enhancement of cannabinoid CB: receptor desensitization in female adolescent rats following repeated Δ-tetrahydrocannabinol exposure. Br J Pharmacol. 2010;161(1):103-112.
37. Rubino T, Vigano' D, Realini N, et al. Chronic delta 9-tetrahydrocannabinol during adolescence provokes sex-dependent changes in the emotional profile in adult rats: behavioral and biochemical correlates. Neuropsychopharmacology. 2008;33 (11):2760-2771.
38. Scallet AC. Neurotoxicology of cannabis and THC: a review of chronic exposure studies in animals. Pharmacol Biochem Behav. 1991;40(3): 671-676.
39. Landfield PW, Cadwallader LB, Vinsant S. Quantitative changes in hippocampal structure following long-term exposure to delta 9-tetrahydrocannabinol: possible mediation by glucocorticoid systems. Brain Res. 1988;443(1-2): 47-62.